Alzheimer, MCI and control samples from AddneuroMed Cohort (batch 1)

Alzheimer case-control samples originate from the EU funded AddNeuroMed Cohort, which is a large cross-European AD biomarker study relying on human blood as the source of RNA. The design is case-control. Cases are either Alzheimer's disease patients, subjects with mild cognitive impairment or age and gender matched controls.

阿尔茨海默病病例对照样本源自欧盟资助的AddNeuroMed队列（AddNeuroMed Cohort），该队列是一项大型跨欧洲阿尔茨海默病（Alzheimer's Disease，AD）生物标志物研究，以人类血液作为RNA的提取来源。本研究采用病例对照研究设计，病例组涵盖阿尔茨海默病患者与轻度认知障碍受试者，对照组为与病例组年龄、性别相匹配的健康对照个体。